Colgate-Palmolive (CL)
NYSE:CL
Want to see CL full AI Analyst Report?
CL Stock Chart & Stats
$85.81
-$0.03(-0.03%)
At close: 4:00 PM EST
$85.81
-$0.03(-0.03%)
Day’s Range― - ―
52-Week Range$74.55 - $99.33
Previous CloseN/A
Volume1.11M
Average Volume (3M)6.07M
Market Cap
$70.01B
Enterprise Value$74.49B
Total Cash (Recent Filing)$1.42B
Total Debt (Recent Filing)$7.97B
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Jul 24, 2026EPS Estimate
0.96Next Dividend Ex-DateN/A
Dividend Yield2.67%
Share Statistics
EPS (TTM)0.97
Shares Outstanding802,301,940
10 Day Avg. Volume5,218,023
30 Day Avg. Volume6,067,427
Financial Highlights & Ratios
PEG Ratio-1.19
Price to Book (P/B)1.18K
Price to Sales (P/S)3.14
P/FCF Ratio17.58
Enterprise Value/Market Cap1.06
Enterprise Value/Revenue3.58
Enterprise Value/Gross Profit5.96
Enterprise Value/Ebitda19.02
Forecast
1Y Price Target
$94.58Price Target Upside10.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
EPS Forecast (FY)3.82
Revenue Forecast (FY)$21.30B
Bulls Say, Bears Say
Bulls Say
Emerging Markets ExposureHeavy exposure to emerging markets combined with demonstrated pricing power should support revenue growth and provide upside versus peers.
Innovation PipelineA robust innovation pipeline across premium oral care, pet nutrition, skincare, and home care, supported by AI-enabled development tools, is expected to drive differentiated product launches and increase sales.
Margin Expansion And Marketing ReallocationReallocating marketing spend toward higher-growth categories and pursuing cost savings initiatives should boost marketing effectiveness and expand gross margins as input pressures moderate.
Bears Say
Delayed Product RelaunchA delayed relaunch of the Optic White product reduced North America oral care consumption and pressured market share, weighing on organic sales.
North America Promotional EnvironmentIntense promotional activity and a low-growth category environment in North America is suppressing sales, causing market share losses and limiting regional growth.
Rising Input Costs And Analyst RevisionsRising oil and resin costs are expected to pressure gross margins and have prompted analysts to lower earnings assumptions and the stock's price target.
Colgate-Palmolive News
CL FAQ
What was Colgate-Palmolive’s price range in the past 12 months?
Colgate-Palmolive lowest stock price was $74.55 and its highest was $99.33 in the past 12 months.
What is Colgate-Palmolive’s market cap?
Colgate-Palmolive’s market cap is $70.01B.
When is Colgate-Palmolive’s upcoming earnings report date?
Colgate-Palmolive’s upcoming earnings report date is Jul 24, 2026 which is in 82 days.
How were Colgate-Palmolive’s earnings last quarter?
Colgate-Palmolive released its earnings results on May 01, 2026. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.943 by $0.027.
Is Colgate-Palmolive overvalued?
According to Wall Street analysts Colgate-Palmolive’s price is currently Undervalued.
Does Colgate-Palmolive pay dividends?
Colgate-Palmolive pays a Quarterly dividend of $0.52 which represents an annual dividend yield of 2.67%. See more information on Colgate-Palmolive dividends here
What is Colgate-Palmolive’s EPS estimate?
Colgate-Palmolive’s EPS estimate is 0.96.
How many shares outstanding does Colgate-Palmolive have?
Colgate-Palmolive has 802,301,940 shares outstanding.
What happened to Colgate-Palmolive’s price movement after its last earnings report?
Colgate-Palmolive reported an EPS of $0.97 in its last earnings report, beating expectations of $0.943. Following the earnings report the stock price went up 2.226%.
Which hedge fund is a major shareholder of Colgate-Palmolive?
Currently, no hedge funds are holding shares in CL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Colgate-Palmolive Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$94.58 (10.23% Upside)
$94.58 (10.23% Upside)
Blogger Sentiment
Bullish
CL Sentiment 90%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 538.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 2.3%
Last 30 Days ▲ 2.3%
News Sentiment
Bearish
Bullish news 25%
Bearish news 75%
Bearish news 75%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-8.44%
12-Months-Change
Fundamentals
Return on Equity
431.59%
Trailing 12-Months
Asset Growth
1.77%
Trailing 12-Months
Company Description
Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
CL Company Deck
CL Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced encouraging operational and strategic progress — accelerated organic sales, volume + pricing gains excluding private-label pet impact, strong Hill's performance, emerging-market momentum, and an expanded productivity program — against meaningful near-term margin headwinds: roughly $300 million of incremental cost pressure, elevated commodity and logistics inflation (>20% and ~10% respectively), gross margin degradation, North America underperformance, and temporary private-label pet disruption. Management maintained overall sales and EPS guidance and emphasized offset plans (RGM, pricing via innovation, productivity/SGPP, disciplined advertising), but acknowledged persistent macro uncertainty.View all CL earnings summariesCL Net sales Breakdown
77.37% Oral, Personal and Home Care
22.63% Pet Nutrition
CL Stock 12 Month Forecast
Average Price Target
$94.58
▲(10.23% Upside)
Technical Analysis
Ownership Overview
0.15% Insiders
21.05% Mutual Funds
5.51% Other Institutional Investors
49.91% Public Companies and Individual Investors